Skip to main content

Advertisement

Log in

An autosomal dominant hypophosphatemic rickets phenotype in a Tunisian family caused by a new FGF23 missense mutation

  • Case Report
  • Published:
Journal of Bone and Mineral Metabolism Aims and scope Submit manuscript

Abstract

Autosomal dominant hypophosphatemic rickets (ADHR) is a rare disease, characterized by isolated renal phosphate wasting, hypophosphatemia, and inappropriately normal 1,25-dihydroxyvitamin D3 (calcitriol) levels. This syndrome involves rickets with bone deformities in childhood and osteomalacia, osteoporosis, articular and para-articular pain, and fatigue in adulthood. It is caused by mutations in a consensus sequence for proteolytic cleavage of the FGF23 protein. Normally, this protein actively regulates phosphate homeostasis. Here we report a Tunisian family in which one parent and three children show clinical and biological features of ADHR. Mutation analysis of the FGF23 gene finds a heterozygous substitution of the C at position 526 by a T (526 C → T), leading to an amino acid replacement of the FGF23 protein (R176W) at position 176. This causative new mutation is located in the consensus sequence for the proteolytic cleavage domain. These results confirm the importance of this site in FGF23 function and its essential role in ADHR physiopathology.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2

Similar content being viewed by others

References

  1. Yu X, White KE (2005) FGF23 and disorders of phosphate homeostasis. Cytokine Growth Factor Rev 16:221–232

    Article  CAS  PubMed  Google Scholar 

  2. Carpenter TO (1997) New perspectives on the biology and treatment of X-linked hypophosphatemic rickets. Pediatr Clin N Am 44:443–466

    Article  CAS  Google Scholar 

  3. Laroche M (2001) Phosphate, the renal tubule, and the musculoskeletal system. Joint Bone Spine 68:211–215

    Article  CAS  PubMed  Google Scholar 

  4. ADHR Consortium (2000) Autosomal dominant hypophosphataemic rickets is associated with mutations in FGF23. Nat Genet 26:345–348

    Article  CAS  Google Scholar 

  5. Bielesz B, Klaushofer K, Oberbauer R (2004) Renal phosphate loss in hereditary and acquired disorders of bone mineralization. Bone 35:1229–1239

    Article  CAS  PubMed  Google Scholar 

  6. Laroche M, Boyer JF (2005) Phosphate diabetes, tubular phosphate reabsorption and phosphatonins. Joint Bone Spine 72:376–381

    Article  PubMed  Google Scholar 

  7. Walton RJ, Bijvoet OL (1975) Nomogram for derivation of renal threshold phosphate concentration. Lancet 2:309–310

    Article  CAS  PubMed  Google Scholar 

  8. Bai XY, Miao D, Goltzman D, Karaplis AC (2003) The autosomal dominant hypophosphatemic rickets R176Q mutation in fibroblast growth factor 23 resists proteolytic cleavage and enhances in vivo biological potency. J Biol Chem 278:9843–9849

    Article  CAS  PubMed  Google Scholar 

  9. Econs MJ, McEnery PT (1997) Autosomal dominant hypophosphatemic rickets/osteomalacia: clinical characterization of a novel renal phosphate-wasting disorder. J Clin Endocrinol Metab 82:674–681

    Article  CAS  PubMed  Google Scholar 

  10. Consortium HYP (1995) A gene (PEX) with homologies to endopeptidases is mutated in patients with X-linked hypophosphatemic rickets. Nat Genet 11:130–136

    Article  Google Scholar 

  11. Caruana RJ, Buckalew VM Jr (1988) The syndrome of distal (type 1) renal tubular acidosis. Clinical and laboratory findings in 58 cases. Medicine (Baltim) 67:84–99

    CAS  Google Scholar 

  12. Clarke BL, Wynne AG, Wilson DM, Fitzpatrick LA (1995) Osteomalacia associated with adult Fanconi’s syndrome: clinical and diagnostic features. Clin Endocrinol (Oxf) 43:479–490

    Article  CAS  Google Scholar 

  13. Econs MJ, McEnery PT, Lennon F, Speer MC (1997) Autosomal dominant hypophosphatemic rickets is linked to chromosome 12p13. J Clin Invest 100:2653–2657

    Article  CAS  PubMed  Google Scholar 

  14. Kaplan FS, Soffer SR, Fallon MD, Haddad JG, Dalinka M, Raffensperger EC (1988) Osteomalacia as a very late manifestation of primary hyperparathyroidism. Clin Orthop Relat Res 228:26–32

    PubMed  Google Scholar 

  15. Lyles KW, Drezner MK (1982) Parathyroid hormone effects on serum 1, 25-dihydroxyvitamin D levels in patients with X-linked hypophosphatemic rickets: evidence for abnormal 25-hydroxyvitamin D-1-hydroxylase activity. J Clin Endocrinol Metab 54:638–644

    Article  CAS  PubMed  Google Scholar 

  16. Monte Neto JT, Sesso R, Kirsztajn GM, Da Silva LC, De Carvalho AB, Pereira AB (1991) Osteomalacia secondary to renal tubular acidosis in a patient with primary Sjogren’s syndrome. Clin Exp Rheumatol 9:625–627

    CAS  PubMed  Google Scholar 

  17. Polisson RP, Martinez S, Khoury M, Harrell RM, Lyles KW, Friedman N, Harrelson JM, Reisner E, Drezner MK (1985) Calcification of entheses associated with X-linked hypophosphatemic osteomalacia. N Engl J Med 313:1–6

    CAS  PubMed  Google Scholar 

  18. Tieder M, Modai D, Shaked U, Samuel R, Arie R, Halabe A, Maor J, Weissgarten J, Averbukh Z, Cohen N, Edelstein S, Liberman U (1987) “Idiopathic” hypercalciuria and hereditary hypophosphatemic rickets. Two phenotypical expressions of a common genetic defect. N Engl J Med 316:125–129

    Article  CAS  PubMed  Google Scholar 

  19. Benet-Pages A, Lorenz-Depiereux B, Zischka H, White KE, Econs MJ, Strom TM (2004) FGF23 is processed by proprotein convertases but not by PHEX. Bone 35:455–462

    Article  CAS  PubMed  Google Scholar 

  20. Liu S, Guo R, Simpson LG, Xiao ZS, Burnham CE, Quarles LD (2003) Regulation of fibroblastic growth factor 23 expression but not degradation by PHEX. J Biol Chem 278:37419–37426

    Article  CAS  PubMed  Google Scholar 

  21. White KE, Carn G, Lorenz-Depiereux B, Benet-Pages A, Strom TM, Econs MJ (2001) Autosomal-dominant hypophosphatemic rickets (ADHR) mutations stabilize FGF-23. Kidney Int 60:2079–2086

    Article  CAS  PubMed  Google Scholar 

  22. Benet-Pages A, Orlik P, Strom TM, Lorenz-Depiereux B (2005) An FGF23 missense mutation causes familial tumoral calcinosis with hyperphosphatemia. Hum Mol Genet 14:385–390

    Article  CAS  PubMed  Google Scholar 

  23. Larsson T, Davis SI, Garringer HJ, Mooney SD, Draman MS, Cullen MJ, White KE (2005) Fibroblast growth factor-23 mutants causing familial tumoral calcinosis are differentially processed. Endocrinology 146:3883–3891

    Article  CAS  PubMed  Google Scholar 

  24. Salles JP (2006) Genetics of hypophosphosphatemia. Arch Pediatr 13:522–524

    Article  PubMed  Google Scholar 

  25. Liu S, Vierthaler L, Tang W, Zhou J, Quarles LD (2008) FGFR3 and FGFR4 do not mediate renal effects of FGF23. J Am Soc Nephrol 19:2342–2350

    Article  CAS  PubMed  Google Scholar 

  26. Yamazaki Y, Tamada T, Kasai N, Urakawa I, Aono Y, Hasegawa H, Fujita T, Kuroki R, Yamashita T, Fukumoto S, Shimada T (2008) Anti-FGF23 neutralizing antibodies show the physiological role and structural features of FGF23. J Bone Miner Res 23:1509–1518

    Article  CAS  PubMed  Google Scholar 

Download references

Acknowledgments

We are indebted to Sihem Sassi, Ahlem Msakni, and Hedi Laatiri for their excellent technical help.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Moez Gribaa.

About this article

Cite this article

Gribaa, M., Younes, M., Bouyacoub, Y. et al. An autosomal dominant hypophosphatemic rickets phenotype in a Tunisian family caused by a new FGF23 missense mutation. J Bone Miner Metab 28, 111–115 (2010). https://doi.org/10.1007/s00774-009-0111-5

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00774-009-0111-5

Keywords

Navigation